Articles & Video
REPORT: Impacts of Decentralized Clinical Trials 2021
Explore the Clinical Trials Series global research study into adoption and impacts on patients, speed and cost of decentralized clinical trials.
Clinical Trials Content Library: Whitepapers and Reports Collection
Explore our collection of exclusive whitepapers and reports covering the hottest topics in clinical trials with one simple registration.
Pfizer: Trial management and manufacturing key to DMD gene therapy success
Pfizer has stressed the importance of its global trial management as it looks to be first to market with its gene therapy for Duchenne muscular dystrophy (DMD).
Science 37 and Foundation Medicine to speed decentralized trial recruitment
Science 37 and Foundation Medicine have partnered to help drug developers accelerate enrolment in decentralized clinical trials.
IQVIA adds AI “virtual agents” to medical info offering
IQVIA will use artificial intelligence (AI) technology to bolster its medical information contact center.
Sponsors running multi country trials must guard against bribery
Globalization of drug research has increased the likelihood of bribery according to new analysis, which suggests the risk is greatest for international, multi-center trials.
ACRO launches remote study toolkit to help CROs secure data
Industry group ACRO says regulators still have concerns about data quality in centralized trials despite backing the approach.
eBook: Diversity, Equity and Inclusion in Biotech & Pharma
Analysis and insights on championing diversity, equity and inclusion from leading biotech and pharmaceutical executives and investors.
MMS launches free support program for ultra-rare diseases
MMS Holdings says a new support scheme will help trial medicines being developed for ultra-rare diseases.
UK OK for Indoco’s CRO Anacipher
The MHRA has cleared Hyderabad based CRO Anacipher to trial drugs destined for the UK market after a “virtual” inspection.
Scope to help new JV Ketabon test oral ketamine for depression
Scope International will manage trials examining an oral formulation of the anesthetic ketamine as a treatment for depression under a contract with newly formed developer Ketabon.
CROs must make trial site assessments more efficient says ASCO
Industry needs to get better at trial site assessment according to American Society of Clinical Oncology (ASCO), which says there is an urgent need to make the process more efficient.
Effective trial data management even more vital during COVID-19, says study
COVID-19 has underlined the importance of efficient, secure data management in clinical trials, according to research by IBM and US-based CRO Veristat.
Planning key to mastering digital master trials, researchers
Sponsors and CROs running so-called “master trials” with digital tech should spend significant time on operational approaches, according to a new study.
COVID has set the stage for trials to go digital say researchers
Clinical trials will enter the digital age according to Indian researchers who say the COVID-19 pandemic has finally convinced CROs to swap pen and paper for data.
Trial starts above 2019 levels according to IQVIA
Clinical trial activity has recovered according to IQVIA, which raised its full year forecast citing new business wins by its study division as a major driver.
Clinlogix becomes third takeover in a year for device CRO NAMSA
Device CRO NAMSA says Clinlogix will extend its global reach and expand its range of disease expertise.
PRA and Icon’s order books boosted by COVID-19
PRA Health Sciences’ clinical business saw a surge in demand in the second quarter according to Icon, which highlighted its new acquisition as a major growth driver.
KoreaBio: COVID-19 driving CRO sector M&A surge
The CRO sector has grown during the COVID-19 pandemic, with higher demand – particularly for decentralized studies –increasing M&A activity according to industry group KoreaBio.